Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Persistent prurigo nodularis responsive to initiation of combination therapy with raltegravir.

Unemori P, Leslie KS, Maurer T.

Arch Dermatol. 2010 Jun;146(6):682-3. doi: 10.1001/archdermatol.2010.128. No abstract available.

2.

Raltegravir: in treatment-naive patients with HIV-1 infection.

Croxtall JD, Scott LJ.

Drugs. 2010 Mar 26;70(5):631-42. doi: 10.2165/11204590-000000000-00000. Review.

PMID:
20329808
3.

Prurigo nodularis: a review.

Lee MR, Shumack S.

Australas J Dermatol. 2005 Nov;46(4):211-18; quiz 219-20. Review.

PMID:
16197418
4.

Raltegravir: the first HIV-1 integrase strand transfer inhibitor in the HIV armamentarium.

Nguyen BY, Isaacs RD, Teppler H, Leavitt RY, Sklar P, Iwamoto M, Wenning LA, Miller MD, Chen J, Kemp R, Xu W, Fromtling RA, Vacca JP, Young SD, Rowley M, Lower MW, Gottesdiener KM, Hazuda DJ.

Ann N Y Acad Sci. 2011 Mar;1222:83-9. doi: 10.1111/j.1749-6632.2011.05972.x. Review.

PMID:
21434946
5.

[Role of the new molecules in antiretroviral therapy. Position of raltegravir].

Arribas JR.

Enferm Infecc Microbiol Clin. 2008 Nov;26 Suppl 12:53-9. Review. Spanish.

PMID:
19572427
6.

Drug-drug interactions with raltegravir.

Burger DM.

Eur J Med Res. 2009 Nov 24;14 Suppl 3:17-21. Review.

7.

Prurigo nodularis: Picking the right treatment.

Saco M, Cohen G.

J Fam Pract. 2015 Apr;64(4):221-6. Review.

PMID:
25973448
8.

Acute onset insomnia associated with the initiation of raltegravir: a report of two cases and literature review.

Gray J, Young B.

AIDS Patient Care STDS. 2009 Sep;23(9):689-90. doi: 10.1089/apc.2009.0012. Review. No abstract available.

PMID:
19663717

Supplemental Content

Support Center